VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The potential of the TSAFinder tool in hematological oncology

Travis Johnson, PhD, MS, Indiana University School of Medicine, Indianapolis, IN, comments on the potential of TSAFinder, a tool designed to detect tumor-specific antigens, in finding novel antigens for CAR-T therapies to treat hematological malignancies. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter